Stock 002826 TIBET AIM PHARM. INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Tibet AIM Pharm. Inc.

Equities

002826

CNE100002C39

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 06/05/2024 am IST 		5-day change 1st Jan Change
9.19 CNY +3.14% Intraday chart for Tibet AIM Pharm. Inc. +3.49% -22.58%
25/04 Tibet AIM Pharm. Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
02/04 Tranche Update on Tibet AIM Pharm. Inc.'s Equity Buyback Plan announced on October 30, 2023. CI

Business Summary

TIBET AIM PHARM INC is a China-based company principally engaged in the research, design, manufacture and distribution of chemical drugs and Chinese patent medicine. The Company’s products include self-manufacturing medicine and third-party medicine. Self-manufacturing medicine includes miglitol tablets, hongjinxiaojie tablet, aceclofenac enteric-coated tablets, montmorillonite powder, as well as domperidone tablets, among others. Its third-party medicine includes gualoupi injection, nalmefene hydrochloride injection, oral liquid for children, cefotaxime sodium for injection, as well as carbetocin injection. The Company distributes its products within domestic market and to overseas markets.

Number of employees: 447

Sales per Business

CNY in Million2021Weight2022Weight Delta
Snakegourd Skin Injections
39.2 %
332 45.8 % 336 39.2 % +1.19%
Miglitol Tablets
38.0 %
190 26.2 % 326 38.0 % +71.43%
Others
8.0 %
66 9.1 % 68 8.0 % +2.80%
Carbetocin Injection
6.6 %
65 9.0 % 57 6.6 % -12.85%
Hongjin Jiejie Tablets
6.2 %
41 5.7 % 53 6.2 % +29.73%
Nalmefene Hydrochloride Injection
1.9 %
31 4.2 % 17 1.9 % -46.01%

Sales per region

CNY in Million2021Weight2022Weight Delta
China
100.0 %
725 100.0 % 857 100.0 % +18.10%

Managers

Managers TitleAgeSince
Ke Xu CEO
 Chief Executive Officer 46 01/10/01
Min Zhou DFI
 Director of Finance/CFO 37 01/23/01
Ling Li CHM
 Chairman 55 01/20/01
Yu Zhang BRD
 Director/Board Member 44 01/05/01
Zhan Zhou BRD
 Director/Board Member 55 12/14/12
Qian Jin Li IRC
 Investor Relations Contact 47 01/04/01

Members of the board

Members of the board TitleAgeSince
Ming Hu BRD
 Director/Board Member 53 13/21/13
Zhan Zhou BRD
 Director/Board Member 55 12/14/12
Qian Jin Li IRC
 Investor Relations Contact 47 01/04/01
Ke Xu CEO
 Chief Executive Officer 46 01/10/01
Xing Gang Xiao BRD
 Director/Board Member 50 13/21/13
Yu Zhang BRD
 Director/Board Member 44 01/05/01
Li Ting Zhao BRD
 Director/Board Member 42 31/23/31
Ling Li CHM
 Chairman 55 01/20/01
Lan Feng BRD
 Director/Board Member 46 13/21/13
Min Zhou DFI
 Director of Finance/CFO 37 01/23/01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 190,677,750 118,518,598 ( 62.16 %) 4,000,000 ( 2.098 %) 62.16 %

Shareholders

NameEquities%Valuation
Gfund Management Co., Ltd.
0.5013 %
660,200 0.5013 % 790 147 ¥
Western Leadbank Fund Management Co., Ltd
0.3139 %
413,400 0.3139 % 494 770 ¥
SWS MU Fund Management Co., Ltd.
0.1958 %
257,900 0.1958 % 308 662 ¥
Dongxing Asset Management Co. Ltd.
0.0118 %
15,500 0.0118 % 18 551 ¥
Hongde Fund Management Co., Ltd.
0.009265 %
12,200 0.009265 % 14 601 ¥
Everbright PGIM Fund Management Co. Ltd.
0.000076 %
100 0.000076 % 120 ¥
China Southern Asset Management Co., Ltd.
0.000062 %
81 0.000062 % 97 ¥

Company contact information

Tibet Aim Pharm., Inc.

37/F, Building B Liangjiang International

610000, Chengdu

+

http://www.emyy.cn
address Tibet AIM Pharm. Inc.(002826)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sector Other Pharmaceuticals

1st Jan change Capi.
TIBET AIM PHARM. INC. Stock Tibet AIM Pharm. Inc.
-22.58% 243M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+31.52% 690B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+24.05% 546B
JOHNSON & JOHNSON Stock Johnson & Johnson
-5.21% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+17.02% 323B
ABBVIE INC. Stock AbbVie Inc.
+5.01% 287B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.02% 235B
NOVARTIS AG Stock Novartis AG
+4.55% 199B
ROCHE HOLDING AG Stock Roche Holding AG
-10.14% 195B
AMGEN INC. Stock Amgen Inc.
+3.98% 161B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 002826 Stock
  4. Company Tibet AIM Pharm. Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW